Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Proof-of-Concept Study of GIC-1001 for the Management of Visceral Pain in Subjects Undergoing Sedation-Free, Full Colonoscopy

NCT01926444 is registered in ClinicalTrials.gov with gicare Pharma Inc. as lead sponsor.

NCT NCT01926444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01926444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Proof-of-Concept Study of GIC-1001 for the Management of Visceral Pain in Subjects Undergoing Sedation-Free, Full Colonoscopy
Lead sponsor
gicare Pharma Inc.
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2013
Completion date
March 31, 2014
Enrollment
308 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, colonic diseases, pain